期刊文献+

幽门螺杆菌VacA重组蛋白表达、纯化及鉴定 被引量:2

Expression,purification and identification of the recombinant VacA of Helicobacter pylori
下载PDF
导出
摘要 目的研究幽门螺杆菌空泡毒素(VacA)编码基因在大肠埃希菌中的表达及纯化重组蛋白的抗原性。方法将PET32 a-vacAE-.coliBL21(DE3)工程菌株常规培养,碱裂解法小量提取重组质粒DNA,琼脂糖凝胶电泳进行酶切鉴定,基因测序法进行插入基因序列分析。重组蛋白采用IPTG诱导表达,镍亲和层析原理提纯,ELISA法检测其抗原性。结果经酶切鉴定表明,插入的基因片段全长约2 240 bp,测序分析及与Genebank比较,可以肯定插入片段为vacA基因,ELISA法检测重组蛋白具有良好的抗原性。结论VacA重组蛋白在大肠埃希菌中成功表达,重组蛋白具有良好的抗原性。 Objective To express the VacA recombinant protein of Helicobacter pylori(H, pylori) in E. coli and identify the antigenity of the purified protein. Methods The pET32a-vacA-E, coli BL21 ( DE3 ) was cultivated in LB liquid culture medium. The pET32a reeombinanted plasmid was extracted and purified by alkaline method and analysed by restriction endonuclease of EcoR I ,Xho I enzyme ,vacA gene was analysed by sequencing. The recombination protein expression induced by IPTG and purified by 6Xhis marked Ni-TEDTM kit. The antigenicity of the protein was analysed by ELISA. Results The inserted gene was vacA and it had about 2 240 bp. The recombinant VacA was expressed in E. coli. ELISA method examination shown that the recombianant protein had good antigenicity. Conclusion The recombinant protein could be expressed successfully in E. coli BL21 (DE3) and it had good antigenicity.
出处 《中国微生态学杂志》 CAS CSCD 2006年第1期27-28,共2页 Chinese Journal of Microecology
关键词 螺杆菌 幽门 VACA 重组蛋白 表达 纯化 Helicobacter pylori Vacolating cytotoxin Recombinantion protein Expression Purification.
  • 相关文献

参考文献2

二级参考文献13

  • 1[1]Parsonnet J,Friedman GD,Vandersteen DP.Helicobacter pylori infection and the risk of gastric carcinoma.New Engl J Med,1991; 325:1127 - 1131
  • 2[2]Parsonnet J,Hansen S,Rodriguez L.Helicobacter pylori infection and gastric lymphorma.NewEnglJMed,1994;330:1267-1271
  • 3[3]Wotherspoon AC.Gastric MALT lymphoma and Helicobacter pylori.Yale J Biol Med,1997;69:61-68
  • 4[4]The European Helicobacter pylori study Group (EHPSA).Current european concepts in the management of Helicobacter pylori infection-the Maastricht consensus report.Gut,1997;41:8 - 13
  • 5[7]Hansson LE,Nyren O,Hsing AW.The risk of stomach cancer in patients with gastric cancer or duodenal ulcer disease.New Engl J Med,1996; 335:242 - 249
  • 6[8]Cerutti PA.Oxy-radicals and cancer.Lancet,1994;344:862-863
  • 7[9]Renault B,Van den Broek M,Fodde R.Base transitions are the most frequent genetic changes at p53 in gastric cancer.Cancer Res,1993; 53:2614 - 2617
  • 8[10]Hongyo T,Buzard GS,Palli D.Mutations of the K-ras and p53 genes in gastric edenocarcinoma from a hign-incidence ragion around Florence,Italy.Cancer Res,1995; 55:2665 - 2672
  • 9[11]Imazeki F,Omata M,Nose H,Ohto M,Isono K.p53 gene mutations in gastric and esophagel Cancers.Gastroenterology,1992; 103:892 - 896
  • 10[13]Nakatsura S,Yanagisawa A,Ichii S.Somatic mutations of the APC gene in gastric cancer:freguent mutations in very well differentiated adenocarcinoma and signet ring cell carcinoma.Hum Mol Genet,1992; 1:559 - 563

共引文献63

同被引文献21

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部